Your browser doesn't support javascript.
loading
Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron.
Ison, Michael G; Popejoy, Myra; Evgeniev, Nikolay; Tzekova, Maria; Mahoney, Kathryn; Betancourt, Natalia; Li, Yong; Gupta, Deepali; Narayan, Kristin; Hershberger, Ellie; Connolly, Lynn E; Yalcin, Ilker; Das, Anita F; Genge, John; Smith, Michelle; Campanaro, Ed; Hawn, Pamela; Schmidt, Pete.
Afiliação
  • Ison MG; Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA.
  • Popejoy M; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Evgeniev N; Complex Oncological Center, Ruse Pltd, Ruse, Bulgaria.
  • Tzekova M; Department of Propedeutics of Internal Diseases, Medical University, Pleven, Bulgaria.
  • Mahoney K; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Betancourt N; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Li Y; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Gupta D; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Narayan K; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Hershberger E; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Connolly LE; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Yalcin I; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Das AF; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Genge J; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Smith M; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Campanaro E; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Hawn P; Invivyd, Inc, Waltham, Massachusetts, USA.
  • Schmidt P; Invivyd, Inc, Waltham, Massachusetts, USA.
Open Forum Infect Dis ; 10(6): ofad279, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37351456

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article